%0 Journal Article
%T International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
%A A. John Camm
%A Ajay K. Kakkar
%A Alexander G. G. Turpie
%A Jan Beyer-Westendorf
%A Jean-Yves Le Heuzey
%A Keith A. A. Fox
%A Saverio Virdone
%A Sylvia Haas
%A for the RIVER Registry Investigators
%J Archive of "Thrombosis Journal".
%D 2019
%R 10.1186/s12959-019-0195-7
%X The online version of this article (10.1186/s12959-019-0195-7) contains supplementary material, which is available to authorized users
%K Anticoagulant
%K Antithrombotic
%K Atrial fibrillation
%K Outcomes
%K Registry
%K Rivaroxaban
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482585/